PRIMENENIE PANTOPRAZOLA V SKhEMAKh POSLEDOVATEL'NOY TERAPII HELICOBACTER PYLORI-INFEKTsII


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article presents the results of a comparative study of two schemes of modified consecutive antihelicobacter therapy: the first scheme included the lengthening of the period of treatment up to 14 days - 7 days at each stage, and the second scheme included the drug bismuth (De-Nol) for the all period of therapy (14 days). Pantoprazole (Controloc) was used in these schemes as a proton pump inhibitor. The results showed that consecutive therapy with Controloc and including De-Nol provides the eradication rate of more than 90 %, and can be a good alternative to current eradication schemes of first-line treatment of patients with H. pylori infection.

Full Text

Restricted Access

References

  1. Graham DY, Fischbach L. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut 2010;59:1143-53.
  2. Kadayifci A, Buyukhatipoglu H, Cemil Savas M, Simsek I. Eradication of Helicobacter pylori with triple therapy: an epidemiologic analysis of trends in Turkey over 10 years. Clin Ther 2006;28:1960-66.
  3. Saad RJ, Chey WD. Treatment of Helicobacter pylori infection in 2006. Gastroenterol Hepatol Annu Rev 2006;1:30-56.
  4. Malfertheiner P, Megraud F, OMorain C, et al. Current concepts in the management of Helicobacter pylori infection. The Maastricht III Consensus Report. Gut 2007;56:772-81.
  5. Malfertheiner P, Megraud F, O'Morain CA, et al. Management of Helicobacter pylori infection -the Maastricht IV/Florence Consensus Report. Gut 2012;61:646-64.
  6. De Francesco V, MargottaM, Zullo A, et al. Claritromicin resistence and Helicobacter pylori genotypes in Italy. J Microbiol 2006; 44(6):660-64.
  7. Marshall B. Sequential therapy for Helicobacter pylori: a worthwhile effort for your patients. Ann Intern Med 2008;148:962-63.
  8. Caselli M, Zullo A, Maconi G, et al. Cervia II Working Group Report 2006: guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy. Dig Liver Dis 2007;39:782-89.
  9. Chey WD, Wong BCY. American College of Gastroenterology Guideline on the Management of Helicobacter pylori Infection. Am J Gastroenterol 2007;102:1808-25.
  10. Vaira D, Zullo A, Vakil N, et al. Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized trial. Annals of Internal Medicine 2007;146(8):556-63.
  11. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis: The updated Sydney System. Am J Surg Pathol 1996;20:1161-81.
  12. Laheij RJ, Rossum LG, Jansen JB, et al. Evaluation of treatment regimens to cure Helicobacter pylori infection - a meta-analysis. Aliment Pharmacol Ther 1999;13:857-64.
  13. Зайцева Н.В., Аминова А.И., Щербаков П.Л. и др. Перспективы использования нитрофурановых препаратов в схемах эрадикации Helicobacter pyloriy детей // Фарматека 2008. № 5. С. 86-90.
  14. Zullo A, Rinaldi V, Winn S, et al. A new highly effective shortterm therapy schedule for Helicobacter pylori eradication. Aliment Pharmacol Ther 2000;14:715-18.
  15. De Francesco V, Zullo A, Hassan C, et al. Two new treatment regimens for Helicobacter pylori eradication: a randomised study. Dig Liver Dis 2001;33:676-79.
  16. Phillips RH, Whitehead MW, Lacey S, et al. Solubility, absorption, and anti-Helicobacter pylori activity of bismuth subnitrate and colloidal bismuth subcitrate: In vitro data Do not predict In vivo efficacy. Helicobacter 2000;5: 176-82.
  17. Григорьев П.Я., Яковенко А. В., Яковенко Э.П. и др. Пути оптимизации лечения Helicobacter pylori-инфекции сравнительная эффективность тройной и квадротерапии, используемых в качестве схем первой линии. Экспериментальная гастроэнтерология 2004. № 5. С. 31-8.
  18. Graham DY, Osato MS, Hoffman J, et al. Metronidazole containing guadruple therapy for infection with. metronidazole resistant Helicobacter pylori: a prospective study. Aliment Pharmacol Ther 2000;14:745-50.
  19. Яковенко А.В., Григорьев П.Я., Яковенко Э.П. и др. Цитопротекторы в терапии заболеваний желудка. Оптимальный подход к выбору препарата // Клиническая и экспериментальная гастроэнтерология 2006. № 2. С. 56-60.
  20. Fitton A, Wiseman L. Pantoprazole: a review of its pharmacological properties and therapeutic use in acidrelated disorders. Drugs 1996;51(3):460-82.
  21. Reill L, Erhardt F, Fischer R, et al. Effect of oral pantoprazole on 24-hour intragastric pH, serum gastrin profile and drug metabolising enzyme activity in man - a placebo-controlled comparison with ranitidine (abstract no.F252). Gut 1993;34(4):63.
  22. Huber R, Hartmann M, Bliesath H, et al. Pharmacokinetics of pantoprazole in man. Int J Clin Pharmacol Ther 1996;34(5):185-94.
  23. Tanaka M, Ohkubo T, Otani K, et al. Metabolic disposition of pantoprazole, a proton pump inhibitor, in relation to S-mephenytoin 4-hydroxylation phenotype and genotype. Clin Pharmacol Ther 1997;62(6):619-28.
  24. Григорьев П.Я. Helicobacter pylori: гастрит, дуоденит, (гастродуоденит), язвенная болезнь // Практикующий врач 1999. № 16. С. 2-6.
  25. Парфенов А.И., Ручкина И.Н., Осипов Г.А. Висмута трикалия дицитрат в лечении больных постинфекционным синдромом раздраженного кишечника // РМЖ 2006. Т. 8. № 2. С. 78-81.
  26. Яковенко Э.П., Агафонова Н.А., Похальская О.Ю. и др. Применение висмута трикалия дицитрата (Де-Нола) - перспективное направление в патогенетической терапии синдрома раздраженного кишечника с диареей // Клин. медицина 2008. № 10. С. 47-52.
  27. Canducci F, Armuzzi A, Cremonini F, at al. A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates // Aliment Pharmacol Ther 2000;14:1625-29.
  28. Cremonini F, Di Caro S, Covino M, et al. Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects. Am J Gastroenterol 2002;97:2744-49.
  29. Яковенко Э.П., Григорьев П.Я., Яковенко А.В. и др. Влияние пробиотика бифиформ на эффективность лечения инфекции helicobacter pylori // Тер. архив 2006. Т. 78. № 2. С. 21-6.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2013 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies